Abiomed, Inc.
ABMDNASDAQHealthcare
$381.02
+$0.00(+0.00%)
Market Cap$17.2B
P/E Ratio—
52W High$381.99
52W Low$219.845
Abiomed, Inc. (ABMD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ABMD · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2022Report Date: Nov 1, 2022EPS Actual
$1.30
Est. $1.04 · +25.0%
Revenue
$0.27B
Fiscal Period
Q4 FY2022
FY ends December
Report Date
Nov 1, 2022
After Market Close
▲ Beat EPS🔥 8-Quarter EPS Beat Streak
ABMD reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2023 | Nov 3, 2023 | — | — | — | — | $0.30B | — |
| ◌ Q3 FY2023 | Aug 2, 2023 | — | — | — | — | $0.30B | — |
| ◌ Q2 FY2023 | Apr 26, 2023 | — | — | — | — | $0.30B | — |
| ◌ Q1 FY2023 | Feb 2, 2023 | $1.03 | — | — | — | $0.29B | — |
| ▲ Q4 FY2022 | Nov 1, 2022 | $1.04 | $1.30 | +25.0% | $0.27B | — | — |
| ▲ Q3 FY2022 | Aug 4, 2022 | $1.06 | $1.25 | +17.9% | $0.28B | — | — |
| ▲ Q2 FY2022 | Apr 28, 2022 | $1.09 | $1.16 | +6.4% | $0.27B | $0.25B | +6.9% |
| ▲ Q1 FY2022 | Feb 3, 2022 | $0.95 | $1.13 | +18.9% | $0.26B | $0.27B | -2.1% |
Q4 FY2023
Nov 3, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 2, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
Apr 26, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Feb 2, 2023
EPS Actual
—
EPS Est.
$1.03
EPS Surpr.
—
Revenue
—
Q4 FY2022
Nov 1, 2022Beat
EPS Actual
$1.30
EPS Est.
$1.04
EPS Surpr.
+25.0%
Revenue
$0.27B
Q3 FY2022
Aug 4, 2022Beat
EPS Actual
$1.25
EPS Est.
$1.06
EPS Surpr.
+17.9%
Revenue
$0.28B
Q2 FY2022
Apr 28, 2022Beat
EPS Actual
$1.16
EPS Est.
$1.09
EPS Surpr.
+6.4%
Revenue
$0.27B
Q1 FY2022
Feb 3, 2022Beat
EPS Actual
$1.13
EPS Est.
$0.95
EPS Surpr.
+18.9%
Revenue
$0.26B
No analyst estimates available for ABMD.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2022 | Nov 1, 2022 | +25.0% | $252.08 | $377.82 | +49.88% |
| ▲ Q3 FY2022 | Aug 4, 2022 | +17.9% | $301.46 | $292.24 | -3.06% |
| ▲ Q2 FY2022 | Apr 28, 2022 | +6.4% | $277.15 | $287.22 | +3.63% |
| ▲ Q1 FY2022 | Feb 3, 2022 | +18.9% | $307.96 | $290.52 | -5.66% |
| ▲ Q4 FY2021 | Oct 28, 2021 | +6.2% | $344.58 | $343.14 | -0.42% |
| ▲ Q3 FY2021 | Aug 4, 2021 | +34.3% | $326.52 | $331.20 | +1.43% |
| ▲ Q2 FY2021 | Apr 29, 2021 | +12.7% | $351.17 | $322.94 | -8.04% |
| ▲ Q1 FY2021 | Jan 28, 2021 | +19.5% | $328.60 | $355.13 | +8.07% |
Q4 FY2022+49.88%
Report Date
Nov 1, 2022
EPS Beat/Miss
+25.0%
Price Before
$252.08
Price After
$377.82
Q3 FY2022-3.06%
Report Date
Aug 4, 2022
EPS Beat/Miss
+17.9%
Price Before
$301.46
Price After
$292.24
Q2 FY2022+3.63%
Report Date
Apr 28, 2022
EPS Beat/Miss
+6.4%
Price Before
$277.15
Price After
$287.22
Q1 FY2022-5.66%
Report Date
Feb 3, 2022
EPS Beat/Miss
+18.9%
Price Before
$307.96
Price After
$290.52
Q4 FY2021-0.42%
Report Date
Oct 28, 2021
EPS Beat/Miss
+6.2%
Price Before
$344.58
Price After
$343.14
Q3 FY2021+1.43%
Report Date
Aug 4, 2021
EPS Beat/Miss
+34.3%
Price Before
$326.52
Price After
$331.20
Q2 FY2021-8.04%
Report Date
Apr 29, 2021
EPS Beat/Miss
+12.7%
Price Before
$351.17
Price After
$322.94
Q1 FY2021+8.07%
Report Date
Jan 28, 2021
EPS Beat/Miss
+19.5%
Price Before
$328.60
Price After
$355.13
Avg Beat Reaction+5.73%
Beat Rate8 / 8 quarters
Largest Move+49.88% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ABMD ends December
Abiomed, Inc. (ABMD) most recently reported earnings on November 1, 2022 for Q4 FY2022, posting EPS of $1.30 — beating the analyst consensus of $1.04 by +25.0%. ABMD has beaten EPS estimates for 8 consecutive quarters. The next ABMD earnings date is expected around September 1, 2026.
Each quarter, investors track ABMD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ABMD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ABMD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ABMD earnings · 5 questionsAbiomed, Inc.'s next earnings report is expected around September 1, 2026. ABMD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ABMD historically reports after market close (AMC).
ABMD earnings datewhen is ABMD earningsABMD next earnings datewhen does ABMD report earningsABMD earnings calendar
▸ Source: FMP · Abiomed, Inc. SEC filings · US GAAP · Abiomed, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026